Shareholders’ Equity (Details) $ / shares in Units, $ in Thousands |
6 Months Ended | ||
|---|---|---|---|
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2024
$ / shares
|
Jun. 30, 2025
₪ / shares
|
|
| Shareholders’ Equity [Line Items] | |||
| Ordinary shares authorized (in Shares) | shares | 3,454,112,863 | ||
| Common stock par value (in New Shekels per share) | ₪ / shares | ₪ 0.00001 | ||
| Voting rights | one | ||
| Weighted average fair values at options granted | $ / shares | $ 5.5 | ||
| Weighted average grant date fair value | $ / shares | $ 22.73 | $ 9.64 | |
| Share issued (in Shares) | shares | 1,585,659 | ||
| Unrecognized compensation costs (in Dollars) | $ | $ 68,882 | ||
| Weighted average period | 2 years 9 months 18 days | ||
| Employee Share Purchase Plan [Member] | |||
| Shareholders’ Equity [Line Items] | |||
| Allowable percent increase in number of shares authorized | 1.00% | ||
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award, annual allowable percent increase in number of shares authorized. No definition available.
|
| X | ||||||||||
- Definition Number of additional shares authorized for issuance under share-based payment arrangement. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|